Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

2.0K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.0K
Peptic Ulcer01:27

Peptic Ulcer

27
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
27
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

1.6K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.6K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

628
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
628
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

779
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
779
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

1.5K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel Artificial Intelligence Combining Convolutional Neural Network and Support Vector Machine to Predict Colorectal Cancer Prognosis and Mutational Signatures From Hematoxylin and Eosin Images.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2024
Same author

A case of premortem diagnosis of cardiac tamponade due to pericardial metastasis of rectal cancer.

Oxford medical case reports·2023
Same author

[Preoperative Prognostic Factors in CRS plus HIPEC for Patients with Peritoneal Dissemination of Colorectal Cancer].

Gan to kagaku ryoho. Cancer & chemotherapy·2023
Same author

Retroperitoneal hibernoma resected via laparoscopic surgery.

Asian journal of endoscopic surgery·2023
Same author

[Multiple Intestinal Perforations Caused by Diffuse Large B-Cell Lymphoma-A Case Report].

Gan to kagaku ryoho. Cancer & chemotherapy·2022
Same author

Artificial intelligence predicts lymph node metastasis or risk of lymph node metastasis in T1 colorectal cancer.

International journal of clinical oncology·2022

Related Experiment Video

Updated: Mar 26, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

888

Key Issues Associated with Helicobacter pylori Eradication.

Takashi Kawai1, Fuminori Moriyasu, Akihiko Tsuchida

  • 1Endoscopy Center, Tokyo Medical University Hospital, Tokyo, Japan.

Digestion
|January 21, 2016
PubMed
Summary

Eradicating Helicobacter pylori improves gastric precancerous conditions but may increase risks for esophagitis and aspirin ulcers. Residual gastric cancer risk persists, especially for early depressed types.

More Related Videos

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
10:44

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

Published on: June 18, 2016

10.2K
Author Spotlight: Detection and Treatment of Helicobacter pylori Infection
06:40

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection

Published on: July 28, 2023

4.6K

Related Experiment Videos

Last Updated: Mar 26, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

888
One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
10:44

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

Published on: June 18, 2016

10.2K
Author Spotlight: Detection and Treatment of Helicobacter pylori Infection
06:40

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection

Published on: July 28, 2023

4.6K

Area of Science:

  • Gastroenterology
  • Oncology
  • Microbiology

Background:

  • Helicobacter pylori infection is a major cause of gastric diseases.
  • Gastric atrophy and intestinal metaplasia are precancerous conditions.
  • Eradication therapy is standard for H. pylori infection.

Purpose of the Study:

  • To evaluate the long-term effects of H. pylori eradication on gastric mucosa.
  • To assess the risk of developing other gastric conditions post-eradication.
  • To understand the characteristics of gastric cancer after H. pylori eradication.

Main Methods:

  • Longitudinal study design.
  • Endoscopic evaluation of gastric mucosa.
  • Histopathological analysis of biopsies.
  • Assessment of gastric acid secretion.

Main Results:

  • H. pylori eradication led to improvement in gastric atrophy and intestinal metaplasia.
  • Increased gastric acid secretion was observed post-eradication, particularly in corpus predominant gastritis.
  • A potential increase in the risk of reflux esophagitis and low-dose aspirin ulcers was noted.
  • Gastric cancer risk, though reduced, remained dependent on the baseline extent of atrophy and metaplasia.
  • Post-eradication gastric cancers were frequently early depressed types, challenging endoscopic diagnosis.

Conclusions:

  • While H. pylori eradication benefits precancerous lesions, it can alter the gastric environment, potentially increasing risks for other conditions.
  • Ongoing surveillance is crucial as a degree of gastric cancer risk persists after eradication.
  • Further research is needed to improve endoscopic detection of post-eradication gastric cancers.